I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84 | -88.6% | 63,800 | -74.1% | 0.00% | -100.0% |
| Q2 2023 | $736 | +2.4% | 246,308 | +18.5% | 0.00% | 0.0% |
| Q1 2023 | $719 | +265.0% | 207,808 | +341.2% | 0.00% | – |
| Q4 2022 | $197 | -100.0% | 47,100 | -70.8% | 0.00% | -100.0% |
| Q3 2022 | $646,000 | -71.0% | 161,100 | +17.2% | 0.00% | -66.7% |
| Q1 2022 | $2,231,000 | -79.1% | 137,400 | -38.9% | 0.00% | -76.9% |
| Q4 2021 | $10,653,000 | -33.4% | 224,800 | +2.0% | 0.01% | -38.1% |
| Q3 2021 | $15,984,000 | +8.2% | 220,500 | +25.3% | 0.02% | +16.7% |
| Q2 2021 | $14,775,000 | +192.8% | 176,000 | +69.1% | 0.02% | +200.0% |
| Q1 2021 | $5,046,000 | -23.8% | 104,100 | -25.9% | 0.01% | -14.3% |
| Q4 2020 | $6,620,000 | +28.0% | 140,400 | +27.6% | 0.01% | +40.0% |
| Q3 2020 | $5,173,000 | +635.8% | 110,000 | +368.1% | 0.01% | +400.0% |
| Q2 2020 | $703,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |